RE: $1.2bn for Molnupirivir9 Jun 2021 16:35
Yes, if the secret patent is for respiratory diseases as some here (including me) think. Then it would make perfect sense to split the indications so we have Immune, Cancer, Respiratory or 1801, 1802, 1803. Then we could on licence all of them separately. As it currently stands, whoever gets 1801 will get the covid side of things as well. Although good for us, it must have included some complexity (zero's haha) into any negotiations. Only guessing though.